• Je něco špatně v tomto záznamu ?

Formation of keto-type ceramides in palmoplantar keratoderma based on biallelic KDSR mutations in patients

R. Pilz, L. Opálka, A. Majcher, E. Grimm, L. Van Maldergem, S. Mihalceanu, K. Schäkel, A. Enk, F. Aubin, AC. Bursztejn, E. Brischoux-Boucher, J. Fischer, R. Sandhoff

. 2022 ; 31 (7) : 1105-1114. [pub] 20220331

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019083

Functional skin barrier requires sphingolipid homeostasis; 3-ketodihydrosphingosine reductase or KDSR is a key enzyme of sphingolipid anabolism catalyzing the reduction of 3-ketodihydrosphingosine to sphinganine. Biallelic mutations in the KDSR gene may cause erythrokeratoderma variabilis et progressive-4, later specified as PERIOPTER syndrome, emphasizing a characteristic periorifical and ptychotropic erythrokeratoderma. We report another patient with compound heterozygous mutations in KDSR, born with generalized harlequin ichthyosis, which progressed into palmoplantar keratoderma. To determine whether patient-associated KDSR mutations lead to KDSR substrate accumulation and/or unrecognized sphingolipid downstream products in stratum corneum (SC), we analyzed lipids of this and previously published patients with non-identical biallelic mutations in KDSR. In SC of both patients, we identified 'hitherto' unobserved skin ceramides with an unusual keto-type sphingoid base in lesional and non-lesional areas, which accounted for up to 10% of the measured ceramide species. Furthermore, an overall shorter mean chain length of free and bound sphingoid bases was observed-shorter mean chain length of free sphingoid bases was also observed in lesional psoriasis vulgaris SC, but not generally in lesional atopic dermatitis SC. Formation of keto-type ceramides is probably due to a bottle neck in metabolic flux through KDSR and a bypass by ceramide synthases, which highlights the importance of tight intermediate regulation during sphingolipid anabolism and reveals substrate deprivation as potential therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019083
003      
CZ-PrNML
005      
20220804135339.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/hmg/ddab309 $2 doi
035    __
$a (PubMed)34686882
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Pilz, Robert $u Lipid Pathobiochemistry Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany
245    10
$a Formation of keto-type ceramides in palmoplantar keratoderma based on biallelic KDSR mutations in patients / $c R. Pilz, L. Opálka, A. Majcher, E. Grimm, L. Van Maldergem, S. Mihalceanu, K. Schäkel, A. Enk, F. Aubin, AC. Bursztejn, E. Brischoux-Boucher, J. Fischer, R. Sandhoff
520    9_
$a Functional skin barrier requires sphingolipid homeostasis; 3-ketodihydrosphingosine reductase or KDSR is a key enzyme of sphingolipid anabolism catalyzing the reduction of 3-ketodihydrosphingosine to sphinganine. Biallelic mutations in the KDSR gene may cause erythrokeratoderma variabilis et progressive-4, later specified as PERIOPTER syndrome, emphasizing a characteristic periorifical and ptychotropic erythrokeratoderma. We report another patient with compound heterozygous mutations in KDSR, born with generalized harlequin ichthyosis, which progressed into palmoplantar keratoderma. To determine whether patient-associated KDSR mutations lead to KDSR substrate accumulation and/or unrecognized sphingolipid downstream products in stratum corneum (SC), we analyzed lipids of this and previously published patients with non-identical biallelic mutations in KDSR. In SC of both patients, we identified 'hitherto' unobserved skin ceramides with an unusual keto-type sphingoid base in lesional and non-lesional areas, which accounted for up to 10% of the measured ceramide species. Furthermore, an overall shorter mean chain length of free and bound sphingoid bases was observed-shorter mean chain length of free sphingoid bases was also observed in lesional psoriasis vulgaris SC, but not generally in lesional atopic dermatitis SC. Formation of keto-type ceramides is probably due to a bottle neck in metabolic flux through KDSR and a bypass by ceramide synthases, which highlights the importance of tight intermediate regulation during sphingolipid anabolism and reveals substrate deprivation as potential therapy.
650    _2
$a ceramidy $x metabolismus $7 D002518
650    12
$a atopická dermatitida $7 D003876
650    _2
$a epidermis $x metabolismus $7 D004817
650    _2
$a lidé $7 D006801
650    12
$a ichtyóza $7 D007057
650    12
$a palmoplantární hyperkeratóza $x genetika $7 D007645
650    _2
$a mutace $7 D009154
650    _2
$a oxidoreduktasy $x metabolismus $7 D010088
650    _2
$a sfingolipidy $x genetika $x metabolismus $7 D013107
655    _2
$a časopisecké články $7 D016428
700    1_
$a Opálka, Lukáš $u Lipid Pathobiochemistry Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Skin Barrier Research Group, Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic
700    1_
$a Majcher, Adam $u Lipid Pathobiochemistry Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Skin Barrier Research Group, Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic
700    1_
$a Grimm, Elisabeth $u Lipid Pathobiochemistry Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $u Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany
700    1_
$a Van Maldergem, Lionel $u Centre de Génétique Humaine, Université de Franche-Comté, 25000 Besançon, France $u Clinical Investigation Center 1431, National Institute of Health and Medical Research (INSERM), University Hospital, 25000 Besançon, France
700    1_
$a Mihalceanu, Silvia $u Department of Dermatology, Medical Faculty of the University of Heidelberg, 69120 Heidelberg, Germany
700    1_
$a Schäkel, Knut $u Department of Dermatology, Medical Faculty of the University of Heidelberg, 69120 Heidelberg, Germany
700    1_
$a Enk, Alexander $u Department of Dermatology, Medical Faculty of the University of Heidelberg, 69120 Heidelberg, Germany
700    1_
$a Aubin, François $u Service de Dermatologie et INSERM 1098 RIGHT, CHU et UFR Santé, 25000 Besançon, France
700    1_
$a Bursztejn, Anne-Claire $u Department of Dermatology, University Hospital Nancy, 54000 Nancy, France
700    1_
$a Brischoux-Boucher, Elise $u Centre de Génétique Humaine, Université de Franche-Comté, 25000 Besançon, France
700    1_
$a Fischer, Judith $u Institute of Human Genetics, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg im Breisgau, Germany
700    1_
$a Sandhoff, Roger $u Lipid Pathobiochemistry Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany $1 https://orcid.org/0000000337949458
773    0_
$w MED00002077 $t Human molecular genetics $x 1460-2083 $g Roč. 31, č. 7 (2022), s. 1105-1114
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34686882 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135332 $b ABA008
999    __
$a ok $b bmc $g 1822619 $s 1170326
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 31 $c 7 $d 1105-1114 $e 20220331 $i 1460-2083 $m Human molecular genetics $n Hum Mol Genet $x MED00002077
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace